Status:
RECRUITING
Magnesium and Cognition After Stroke
Lead Sponsor:
BDH-Klinik Hessisch Oldendorf
Conditions:
Stroke
Cognition
Eligibility:
All Genders
18+ years
Brief Summary
Cognitive impairments such as memory impairments, word-finding difficulties, compromised orientation and perception are often observed in stroke patients. Low serum-mg-concentrations are associated w...
Detailed Description
Stroke patients admitted to the stroke unit will be included. Initial mg-concentration in serum as well as stroke related measures (National Institutes of Health Stroke Scale, Scandinavian Stroke Scal...
Eligibility Criteria
Inclusion Criteria:
- ischemic/hemmorhagic stroke
- written consent form
Exclusion Criteria:
- pre-existing dementia or cognitive impairment before stroke onset
- pre-existing mental disorder (depression) or present/prior long-term treatment (> 6 months) with psychotropic drugs
- pre-existing malign tumor disease
- participation in another clinical trial within the past 30 days
- pregnancy or breastfeeding
Key Trial Info
Start Date :
October 26 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05132517
Start Date
October 26 2022
End Date
September 30 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Neurorehabilitation Research, BDH-Clinic Hessich Oldendorf
Hessisch Oldendorf, Lower Saxony, Germany, 31840